Literature DB >> 28290647

Syncope: Evaluation and Differential Diagnosis.

Lloyd A Runser1, Robert L Gauer1, Alex Houser1.   

Abstract

Syncope is an abrupt and transient loss of consciousness caused by cerebral hypoperfusion. It accounts for 1% to 1.5% of emergency department visits, resulting in high hospital admission rates and significant medical costs. Syncope is classified as neurally mediated, cardiac, and orthostatic hypotension. Neurally mediated syncope is the most common type and has a benign course, whereas cardiac syncope is associated with increased morbidity and mortality. Patients with presyncope have similar prognoses to those with syncope and should undergo a similar evaluation. A standardized approach to syncope evaluation reduces hospital admissions and medical costs, and increases diagnostic accuracy. The initial assessment for all patients presenting with syncope includes a detailed history, physical examination, and electrocardiography. The initial evaluation may diagnose up to 50% of patients and allows immediate short-term risk stratification. Laboratory testing and neuroimaging have a low diagnostic yield and should be ordered only if clinically indicated. Several comparable clinical decision rules can be used to assess the short-term risk of death and the need for hospital admission. Low-risk patients with a single episode of syncope can often be reassured with no further investigation. High-risk patients with cardiovascular or structural heart disease, history concerning for arrhythmia, abnormal electrocardiographic findings, or severe comorbidities should be admitted to the hospital for further evaluation. In cases of unexplained syncope, provocative testing and prolonged electrocardiographic monitoring strategies can be diagnostic. The treatment of neurally mediated and orthostatic hypotension syncope is largely supportive, although severe cases may require pharmacotherapy. Cardiac syncope may require cardiac device placement or ablation.

Entities:  

Mesh:

Year:  2017        PMID: 28290647

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  6 in total

1.  Diagnosing spells: Machines or humans?

Authors:  Cormac A O'Donovan
Journal:  Neurol Clin Pract       Date:  2020-04

2.  Recurrent syncope is not an independent risk predictor for future syncopal events or adverse outcomes.

Authors:  Anna Marie Chang; Judd E Hollander; Erica Su; Robert E Weiss; Annick N Yagapen; Susan E Malveau; David H Adler; Aveh Bastani; Christopher W Baugh; Jeffrey M Caterino; Carol L Clark; Deborah B Diercks; Bret A Nicks; Daniel K Nishijima; Manish N Shah; Kirk A Stiffler; Alan B Storrow; Scott T Wilber; Benjamin C Sun
Journal:  Am J Emerg Med       Date:  2018-08-24       Impact factor: 2.469

3.  The incidence of acute pulmonary embolism following syncope in anticoagulant-naïve patients: A retrospective cohort study.

Authors:  Danny Epstein; Gidon Berger; Noam Barda; Erez Marcusohn; Yuval Barak-Corren; Khitam Muhsen; Ran D Balicer; Zaher S Azzam
Journal:  PLoS One       Date:  2018-03-07       Impact factor: 3.240

Review 4.  Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine.

Authors:  Matthew W McCarthy
Journal:  Expert Rev Anti Infect Ther       Date:  2020-05-04       Impact factor: 5.091

5.  Neurally Mediated Syncope Triggered by COVID-19 Nasopharyngeal Swab Specimen Collection: A Case Report.

Authors:  William R Bloom; Thomas D Bloom
Journal:  Allergy Rhinol (Providence)       Date:  2022-01-19

6.  The blood-brain barrier disruption after syncope: a dynamic contrast-enhanced magnetic resonance imaging study: A case report.

Authors:  Hyungkyu Huh; Eun-Hee Lee; Sung Suk Oh; Jong-Hoon Kim; Young Beom Seo; Yoo Jin Choo; Juyoung Park; Min Cheol Chang
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.